The high mortality and poor prognosis for women diagnosed with ovarian cancer is mainly due to late diagnosis. Improved detection of primary tumors and recurrence after chemotherapy is, therefore, crucial to reduce ovarian cancer mortality [...]
The treatment of cancer remains an ever-growing problem. Treating solid tumors as a medical disease first, using the natural biology of tumors to reduce or eliminate tumors in situ, offers patients and the entire healthcare [...]
, Evstigneev M.
, Hurmach V.
, Lehka L.
, Panchuk R.
, Piosik J.
, Prylutska S.
, Prylutskyy Yu.
, Scharff P.
, Skivka L.
, Skorokhyd N.
, Stoika R.
, Vari S.
, Institute of Cell Biology NAS of Ukraine, UA
Rapid development of multi-drug resistance of tumor cells to chemotherapy caused by the over-expression of specific ABC-transporter proteins and/or multiple defects in genes involved in cell cycle and apoptosis regulation in cancer cells frequently leads [...]
Development of precision medicines acting specifically at the site of disease has been a long sought goal for the last century, starting from pioneering works of Paul Ehrlich, who suggested the concept of site-directed chemotherapeutics [...]
Journal: TechConnect Briefs
Volume: 3, Biotech, Biomaterials and Biomedical: TechConnect Briefs 2017
Published: May 14, 2017
Industry sector: Medical & Biotech
Topics: Biomaterials, Cancer Nanotechnology